Reference Listed Drugs (RLDs) Supplier

Reference Listed Drugs (RLDs) are FDA-approved innovator medicines used as standards in bioequivalence testing for generics and biosimilars. These products play a critical role in:

• Supporting clinical and bioequivalence (BE) studies
• Facilitating regulatory filings across multiple markets
• Ensuring accurate comparisons for generics and formulations
• Sourcing niche, patented, or difficult-to-access products globally

Ikris Pharma International bridges the access gap by sourcing authentic, batch-certified RLDs from trusted global manufacturers. We ensure full compliance with all relevant regulations and logistics requirements.

• Well-established Network – We source RLDs from 30+ countries, including the USA, EU (Belgium, Bulgaria, Germany, France, Latvia, Poland, Netherlands, etc), Canada, Japan, Australia, and the UK.
• Comparator Drug Expertise – Extensive catalog of originator brands and bioequivalence-compliant batches.
• EU-GDP Certified Warehouse – Fully compliant storage facility operating under EU GDP guidelines with SOPs aligned to European regulatory mandates.

• Controlled Storage & Delivery – Cold chain, ambient, and temperature-specific supply chain solutions.
• 100% Regulatory Documentation – We provide all required documents, including COA (Certificate of Analysis), COC (Certificate of Conformity), COO (Certificate of Origin), Packing List, Batch Numbers, Product Traceability, and Country-Specific Invoices.
• Trusted by CROs & Sponsors – Partnerships with top clinical research organizations and pharma manufacturers.